Interactions of recombinant prions with compounds of therapeutical significance
Authors:
- 2 June 2006
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 344 (2) , 463-470
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Copper Chelation Delays the Onset of Prion DiseaseJournal of Biological Chemistry, 2003
- Expression of Prion Protein Increases Cellular Copper Binding and Antioxidant Enzyme Activities but Not Copper DeliveryJournal of Biological Chemistry, 2003
- Cellular Phenotyping of Secretory and Nuclear Prion Proteins Associated with Inherited Prion DiseasesJournal of Biological Chemistry, 2002
- NMR structure of the bovine prion proteinProceedings of the National Academy of Sciences, 2000
- Copper binding to the prion protein: Structural implications of four identical cooperative binding sitesProceedings of the National Academy of Sciences, 1999
- Copper Stimulates Endocytosis of the Prion ProteinJournal of Biological Chemistry, 1998
- PrionsProceedings of the National Academy of Sciences, 1998
- Human prion proteins expressed in Escherichia coli and purified by high‐affinity column refoldingFEBS Letters, 1997
- A new variant of Creutzfeldt-Jakob disease in the UKThe Lancet, 1996
- Human prion diseasesCurrent Opinion in Neurology, 1995